数位 PCR 市场规模、份额及成长分析（按类型、产品、技术、适应症、应用、最终用户和地区）－2025 年至 2032 年产业预测

2023 年数位 PCR 市场规模价值 83 亿美元，预计将从 2024 年的 90.9 亿美元成长到 2032 年的 187.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.5%。

全球数位 PCR（聚合酵素链锁反应）市场正在经历显着增长，这受到对精确核酸定量和分析的需求不断增长的推动。 dPCR 具有独特的灵敏度和准确性，在研究、疾病诊断和基因检测中至关重要，可为专业人士提供可靠的结果，以改善患者护理并推动科学进步。推动市场发展的因素包括感染疾病和遗传疾病的增加、个人化治疗的推动以及基因组学研究的进步。但设备成本高、认知度低等问题仍存在。最近值得注意的发展包括用于同时进行目标检测的多重数位 PCR 检测的出现以及数位 PCR 与次世代定序仪的整合。此外，新兴市场的日益普及和创新产品的推出也推动了市场的成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 技术分析

数位PCR市场规模（按类型）

• 市场概览
• 数量型
• 数字类型
• 端点类型

数位 PCR 市场规模（依产品划分）

• 市场概览
• 耗材和试剂
• 数位PCR仪器
• 软体和服务

数位PCR市场规模（按技术）

• 市场概览
• 液滴式数位PCR
• 基于晶片的数位PCR
• 其他的

数位PCR市场规模（按适应症）

• 市场概览
• 肿瘤学
• 感染疾病
• 遗传性疾病
• 其他的

数位PCR市场规模（按应用）

• 市场概览
• 临床应用
• 调查应用
• 法医学应用
• 环境应用
• 其他用途

数位 PCR 市场规模（以最终用户划分）

• 市场概览
• 医院和诊断实验室
• 学术研究所
• 製药和生物技术公司
• CRO 和 CDMO
• 法医学实验室
• 其他最终用户

数位PCR市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Bio-Rad Laboratories, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• QIAGEN NV（Germany/Netherlands）
• F. Hoffmann-La Roche AG（Switzerland）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Sysmex Corporation（Japan）
• JN Medsys Pte. Ltd.（Singapore）
• Stilla Technologies SAS（France）
• Standard BioTools Inc.（USA）
• Fluidigm Corporation（USA）
• Avance Biosciences（USA）
• Takara Bio Inc.（Japan）
• Meridian Bioscience（USA）
• Becton, Dickinson and Company（USA）
• Abbott Laboratories（USA）
• Promega Corporation（USA）
• Endress+Hauser Group Services AG（Switzerland）
• Biomerieux（France）
• Eppendorf AG（Germany）

结论和建议

Digital PCR Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 9.09 billion in 2024 to USD 18.78 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global digital PCR (Polymerase Chain Reaction) market is experiencing significant growth, fueled by the rising demand for precise nucleic acid quantification and analysis. Its unique sensitivity and accuracy make digital PCR vital for research, disease diagnosis, and genetic testing, empowering professionals to achieve reliable results that enhance patient care and facilitate scientific advancements. Key market drivers include the increasing prevalence of infectious diseases and genetic disorders, the push for personalized therapies, and advancements in genomic research. However, challenges such as high instrument costs and limited awareness persist. Noteworthy recent trends include the emergence of multiplex digital PCR assays for simultaneous target detection and the integration of digital PCR with next-generation sequencing. Additionally, the growing adoption in developing regions and innovative product launches are propelling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Pcr market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Pcr Market Segments Analysis

Global Digital PCR Market is segmented by Type, Product, Technology, Indication, Application, End User and region. Based on Type, the market is segmented into Quantitative, Digital and End-point. Based on Product, the market is segmented into Consumables & Reagents, Digital PCR Instruments and Software & Services. Based on Technology, the market is segmented into Droplet Digital PCR, Chip-based Digital PCR and Others. Based on Indication, the market is segmented into Oncology, Infectious Disease, Genetic Disorders and Others. Based on Application, the market is segmented into Clinical Applications, Research Applications, Forensic Applications, Environmental Applications and Other Applications. Based on End User, the market is segmented into Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Pcr Market

The digital PCR market is significantly driven by the rising demand for precise diagnostic tools within the healthcare sector. As the industry increasingly embraces precision medicine, there is a heightened need for testing methods that offer high sensitivity and specificity. Digital PCR technology plays a crucial role in clinical diagnostics and research by proficiently detecting genetic alterations, cancer biomarkers, and infectious diseases. The emphasis on quality diagnostics is pivotal in customizing therapies tailored to individual patient needs, further fueling the demand for personalized treatment approaches. This growing requirement for superior diagnostic accuracy is propelling substantial growth in the digital PCR market.

Restraints in the Digital Pcr Market

The digital PCR market faces significant challenges primarily due to the high costs associated with essential equipment and consumables, which pose a substantial barrier, especially for smaller laboratories in developing nations. The financial investment required for the necessary apparatus and reagents can deter access to advanced diagnostic technologies. As a result, many healthcare providers might lean towards more affordable traditional PCR methods, hindering the widespread adoption and integration of digital PCR solutions. This financial constraint ultimately limits the market's growth potential, as the disparity in access can stifle innovation and prevent smaller labs from fully embracing the benefits of digital PCR technology.

Market Trends of the Digital Pcr Market

The digital PCR market is currently experiencing a significant trend marked by the integration of machine learning (ML) and artificial intelligence (AI). This advancement enhances data processing capabilities, allowing for more accurate analysis of complex genetic information. AI algorithms streamline workflows by automating routine tasks and refining experimental designs, ultimately boosting productivity. Furthermore, machine learning facilitates improved modeling, leading to deeper insights into genetic variants and the underlying causes of diseases. As a result, there is a growing demand for sophisticated diagnostic tools across various sectors, which is concurrently increasing the usability and appeal of digital PCR devices, positioning the market for robust growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Digital PCR Market Size by Type & CAGR (2025-2032)

• Market Overview
• Quantitative
• Digital
• End-point

Global Digital PCR Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables & Reagents
• Digital PCR Instruments
• Software & Services

Global Digital PCR Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Droplet Digital PCR
• Chip-based Digital PCR
• Others

Global Digital PCR Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Disease
• Genetic Disorders
• Others

Global Digital PCR Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Applications
• Research Applications
• Forensic Applications
• Environmental Applications
• Other Applications

Global Digital PCR Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Diagnostic Laboratories
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• CROs and CDMOs
• Forensic Laboratories
• Other End Users

Global Digital PCR Market Size & CAGR (2025-2032)

• North America (Type, Product, Technology, Indication, Application, End User)
  • US
  • Canada
• Europe (Type, Product, Technology, Indication, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Technology, Indication, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Technology, Indication, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Technology, Indication, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stilla Technologies SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avance Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endress+Hauser Group Services AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations